[XENE] YoY Quarter Result on 30-Sep-2012 [#Q3]

Stock
[XENE] Xenon Pharmaceuticals Inc.
Announcement Date
29-Sep-2012
Financial Year
2012
Quarter
30-Sep-2012 [#Q3]
Profit Trend
QoQ-
YoY-
Quarter Report
XENE's Result
XENE's Financial Summary
View:
Show?
Quarter Result
30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 CAGR
Revenue 0 264 413 4,294 13,193 10,788 3,049 -
PBT -14,383 -7,742 -7,714 -3,827 9,191 6,378 -1,425 46.98%
Tax 678 -902 383 3,007 0 15 0 -
NP -14,383 -7,742 -7,714 -3,827 9,191 6,378 -1,425 46.98%
Tax Rate - - - - 0.00% -0.24% - -
Total Cost 14,383 8,006 8,127 8,121 4,002 4,410 4,474 21.47%
Ratio Analysis
30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 CAGR
NP Margin 0.00 -2,932.58 -1,867.80 -89.12 69.67 59.12 -46.74 -
Per Share
30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 30/09/12 CAGR
EPS -0.71 -0.43 -0.51 -0.27 0.26 0.99 -1.07 -6.60%
EPS Diluted -0.71 -0.43 -0.51 -0.27 0.26 0.63 -1.07 -6.60%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.